| 1 | Identifying modifiable factors and their joint effect on dementia risk in the UK Biobank | 8.1 | 29 | Citations (PDF) |
| 2 | Personality traits and brain health: a large prospective cohort study | 4.1 | 5 | Citations (PDF) |
| 3 | The dihydrofolate reductase 19-bp deletion modifies the beneficial effect of B-vitamin therapy in mild cognitive impairment: pooled study of two randomized placebo-controlled trials | 3.1 | 7 | Citations (PDF) |
| 4 | The epidemiology is promising, but the trial evidence is weak. Why pharmacological dementia risk reduction trials haven't lived up to expectations, and where do we go from here? | 0.7 | 10 | Citations (PDF) |
| 5 | Vitamin B-12 | 8.3 | 7 | Citations (PDF) |
| 6 | Association of life course adiposity with risk of incident dementia: a prospective cohort study of 322,336 participants | 8.3 | 18 | Citations (PDF) |
| 7 | ω-3 fatty acids and their interactions | 5.1 | 6 | Citations (PDF) |
| 8 | Homocysteine – from disease biomarker to disease prevention | 7.6 | 139 | Citations (PDF) |
| 9 | Paraoxonase 1, B Vitamins Supplementation, and Mild Cognitive Impairment | 2.7 | 22 | Citations (PDF) |
| 10 | Anti‐<i>N</i>‐homocysteine‐protein autoantibodies are associated with impaired cognition | 5.0 | 9 | Citations (PDF) |
| 11 | B Vitamins Prevent Iron-Associated Brain Atrophy and Domain-Specific Effects of Iron, Copper, Aluminum, and Silicon on Cognition in Mild Cognitive Impairment | 2.7 | 14 | Citations (PDF) |
| 12 | Dementia risk reduction: why haven't the pharmacological risk reduction trials worked? An in‐depth exploration of seven established risk factors | 5.0 | 11 | Citations (PDF) |
| 13 | Glutathione Serum Levels and Rate of Multimorbidity Development in Older Adults | 3.6 | 24 | Citations (PDF) |
| 14 | A Machine Learning Approach to Identify a Circulating MicroRNA Signature for Alzheimer Disease | 1.4 | 19 | Citations (PDF) |
| 15 | Vitamin C—An Adjunctive Therapy for Respiratory Infection, Sepsis and COVID-19 | 4.6 | 127 | Citations (PDF) |
| 16 | Expert Opinion on Benefits of Long-Chain Omega-3 Fatty Acids (DHA and EPA) in Aging and Clinical Nutrition | 4.6 | 130 | Citations (PDF) |
| 17 | Association of Homocysteine, Methionine, and <i>MTHFR</i> 677C&gt;T Polymorphism With Rate of Cardiovascular Multimorbidity Development in Older Adults in Sweden | 7.2 | 16 | Citations (PDF) |
| 18 | Nutrition and the ageing brain: Moving towards clinical applications | 12.1 | 68 | Citations (PDF) |
| 19 | Association of Methionine to Homocysteine Status With Brain Magnetic Resonance Imaging Measures and Risk of Dementia | 14.1 | 36 | Citations (PDF) |
| 20 | Evaluation of (−)-epicatechin metabolites as recovery biomarker of dietary flavan-3-ol intake | 3.7 | 23 | Citations (PDF) |
| 21 | Combined Anti-inflammatory and Neuroprotective Treatments Have the Potential to Impact Disease Phenotypes in Cln3−/− Mice | 2.5 | 13 | Citations (PDF) |
| 22 | Dietary Supplements for Brain Health | 13.7 | 0 | Citations (PDF) |
| 23 | The Epistasis Project: A Multi-Cohort Study of the Effects of BDNF, DBH, and SORT1 Epistasis on Alzheimer’s Disease Risk | 2.7 | 10 | Citations (PDF) |
| 24 | Imaging of changes in copper trafficking and redistribution in a mouse model of Niemann-Pick C disease using positron emission tomography | 3.3 | 10 | Citations (PDF) |
| 25 | Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer’s Disease: The OmegAD Study | 2.7 | 49 | Citations (PDF) |
| 26 | N‐homocysteinylation of tau and MAP1 is increased in autopsy specimens of Alzheimer's disease and vascular dementia | 5.2 | 35 | Citations (PDF) |
| 27 | Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing | 16.3 | 1,802 | Citations (PDF) |
| 28 | Interaction of nutrition and genetics via DNMT3L-mediated DNA methylation determines cognitive decline | 3.4 | 8 | Citations (PDF) |
| 29 | The kynurenine pathway and cognitive performance in community-dwelling older adults. The Hordaland Health Study | 4.3 | 49 | Citations (PDF) |
| 30 | Homocysteine and Dementia: An International Consensus Statement | 2.7 | 245 | Citations (PDF) |
| 31 | Biomarkers of Nutrition for Development (BOND): Vitamin B-12 Review | 3.0 | 187 | Citations (PDF) |
| 32 | Maternal and infant vitamin B12 status and development | 2.1 | 0 | Citations (PDF) |
| 33 | Vitamin B12 | 0.0 | 121 | Citations (PDF) |
| 34 | Dementia research priorities—2 | 19.1 | 6 | Citations (PDF) |
| 35 | The soluble transcobalamin receptor (sCD320) in relation to Alzheimer’s disease and cognitive scores | 1.3 | 0 | Citations (PDF) |
| 36 | Folic Acid for the Prevention of Neural Tube Defects | 9.5 | 2 | Citations (PDF) |
| 37 | Kynurenine Pathway Metabolites in Alzheimer’s Disease | 2.7 | 99 | Citations (PDF) |
| 38 | Mutation analysis of sporadic early-onset Alzheimer's disease using the NeuroX array | 3.4 | 24 | Citations (PDF) |
| 39 | Elevated homocysteine and N-methyl-d-aspartate-receptor antibodies as a cause of behavioural and cognitive decline in 22q11.2 deletion syndrome | 0.4 | 5 | Citations (PDF) |
| 40 | Association of Vitamin B<sub>12</sub>, Folate, and Sulfur Amino Acids With Brain Magnetic Resonance Imaging Measures in Older Adults | 14.1 | 80 | Citations (PDF) |
| 41 | B‐vitamins are potentially a cost‐effective population health strategy to tackle dementia: Too good to be true? | 5.0 | 16 | Citations (PDF) |
| 42 | Evidence-based prevention and treatment of dementia | 19.1 | 0 | Citations (PDF) |
| 43 | Homocysteine, B Vitamins, and Cognitive Impairment | 11.4 | 367 | Citations (PDF) |
| 44 | Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment | 2.7 | 122 | Citations (PDF) |
| 45 | ABCA7 p.G215S as potential protective factor for Alzheimer's disease | 3.4 | 43 | Citations (PDF) |
| 46 | Hippocampus as a mediator of the role of vitamin B-12 in memory | 5.1 | 10 | Citations (PDF) |
| 47 | Screening exons 16 and 17 of the amyloid precursor protein gene in sporadic early-onset Alzheimer's disease | 3.4 | 13 | Citations (PDF) |
| 48 | The Effects of Two Polymorphisms on p21cip1 Function and Their Association with Alzheimer’s Disease in a Population of European Descent | 2.5 | 14 | Citations (PDF) |
| 49 | Homocysteine lowering, B vitamins, and cognitive aging | 5.1 | 17 | Citations (PDF) |
| 50 | Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial | 5.1 | 162 | Citations (PDF) |
| 51 | Cerebrospinal Fluid Biomarkers Distinguish Postmortem-Confirmed Alzheimer's Disease from Other Dementias and Healthy Controls in the OPTIMA Cohort | 2.7 | 69 | Citations (PDF) |
| 52 | Cerebral Amyloid Angiopathy, Subcortical White Matter Disease and Dementia: Literature Review and Study in <scp>OPTIMA</scp> | 4.7 | 47 | Citations (PDF) |
| 53 | A novel Alzheimer disease locus located near the gene encoding tau protein | 8.3 | 203 | Citations (PDF) |
| 54 | High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer’s Disease in Human Cerebrospinal Fluid | 2.5 | 53 | Citations (PDF) |
| 55 | Interactions between plasma concentrations of folate and markers of vitamin B<sub>12</sub>status with cognitive performance in elderly people not exposed to folic acid fortification: the Hordaland Health Study | 2.7 | 41 | Citations (PDF) |
| 56 | Cerebral Subcortical Small Vessel Disease in Subjects With Pathologically Confirmed Alzheimer Disease | 1.5 | 39 | Citations (PDF) |
| 57 | Discovery by the Epistasis Project of an epistatic interaction between the GSTM3 gene and the HHEX/IDE/KIF11 locus in the risk of Alzheimer's disease | 3.4 | 25 | Citations (PDF) |
| 58 | Dysfunction of the mTOR pathway is a risk factor for Alzheimer’s disease | 5.1 | 58 | Citations (PDF) |
| 59 | The impact of early life factors on cognitive function in old age: The Hordaland Health Study (HUSK) | 2.8 | 7 | Citations (PDF) |
| 60 | Preventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment | 7.7 | 408 | Citations (PDF) |
| 61 | Structural and functional bases of visuospatial associative memory in older adults | 3.4 | 16 | Citations (PDF) |
| 62 | Cognitive Function in an Elderly Population | 2.3 | 56 | Citations (PDF) |
| 63 | Human hippocampal energy metabolism is impaired during cognitive activity in a lipid infusion model of insulin resistance | 2.5 | 36 | Citations (PDF) |
| 64 | Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer’s disease | 40.1 | 380 | Citations (PDF) |
| 65 | The sex-specific associations of the aromatase gene with Alzheimer’s disease and its interaction with IL10 in the Epistasis Project | 3.1 | 33 | Citations (PDF) |
| 66 | Cysteine and obesity | 3.2 | 91 | Citations (PDF) |
| 67 | The Role of Variation at AβPP, PSEN1, PSEN2, and MAPT in Late Onset Alzheimer's Disease | 2.7 | 50 | Citations (PDF) |
| 68 | Transferrin and HFE genes interact in Alzheimer's disease risk: the Epistasis Project | 3.4 | 49 | Citations (PDF) |
| 69 | 74 Disease-modification in mild cognitive impairment by lowering homocysteine | 3.4 | 1 | Citations (PDF) |
| 70 | Identification of SPARC-like 1 Protein as Part of a Biomarker Panel for Alzheimer's Disease in Cerebrospinal Fluid | 2.7 | 49 | Citations (PDF) |
| 71 | Cognitive and clinical outcomes of homocysteine‐lowering B‐vitamin treatment in mild cognitive impairment: a randomized controlled trial | 2.4 | 340 | Citations (PDF) |
| 72 | Do we need to reconsider the desirable blood level of vitamin B12? | 7.6 | 47 | Citations (PDF) |
| 73 | Cysteine and Obesity | 4.3 | 55 | Citations (PDF) |
| 74 | Dietary cystine level affects metabolic rate and glycaemic control in adult mice | 4.9 | 49 | Citations (PDF) |
| 75 | Vitamin B-12 Status during Pregnancy and Child’s IQ at Age 8: A Mendelian Randomization Study in the Avon Longitudinal Study of Parents and Children | 2.5 | 29 | Citations (PDF) |
| 76 | Cysteine supplementation reverses methionine restriction effects on rat adiposity: significance of stearoyl-coenzyme A desaturase | 3.7 | 129 | Citations (PDF) |
| 77 | Non-linear relationships of cerebrospinal fluid biomarker levels with cognitive function: an observational study | 6.7 | 22 | Citations (PDF) |
| 78 | Upregulation of AMPA receptor GluR2 (GluA2) subunits in subcortical ischemic vascular dementia is repressed in the presence of Alzheimer's disease | 3.6 | 15 | Citations (PDF) |
| 79 | The vitamin D receptor gene is associated with Alzheimer's disease | 1.9 | 72 | Citations (PDF) |
| 80 | A Multi-Center Study of ACE and the Risk of Late-Onset Alzheimer's Disease | 2.7 | 29 | Citations (PDF) |
| 81 | Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease | 16.3 | 1,637 | Citations (PDF) |
| 82 | No evidence that extended tracts of homozygosity are associated with Alzheimer's disease | 1.8 | 14 | Citations (PDF) |
| 83 | Interaction of insulin and PPAR-α genes in Alzheimer’s disease: the Epistasis Project | 3.6 | 17 | Citations (PDF) |
| 84 | Homocysteine as a predictor of cognitive decline in Alzheimer's disease | 2.4 | 92 | Citations (PDF) |
| 85 | Genome wide profiling of altered gene expression in the neocortex of Alzheimer's disease | 3.3 | 101 | Citations (PDF) |
| 86 | Cognitive performance among the elderly in relation to the intake of plant foods. The Hordaland Health Study | 2.7 | 80 | Citations (PDF) |
| 87 | Sulfur amino acids in methionine-restricted rats: Hyperhomocysteinemia | 2.8 | 82 | Citations (PDF) |
| 88 | The dopamine β-hydroxylase -1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project | 2.1 | 49 | Citations (PDF) |
| 89 | Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease | 2.5 | 328 | Citations (PDF) |
| 90 | Associations of Folate, Vitamin B12, Homocysteine, and Folate-Pathway Polymorphisms with Prostate-Specific Antigen Velocity in Men with Localized Prostate Cancer | 0.9 | 19 | Citations (PDF) |
| 91 | Concordant Association of Insulin Degrading Enzyme Gene (IDE) Variants with IDE mRNA, Aß, and Alzheimer's Disease | 2.5 | 48 | Citations (PDF) |
| 92 | Folic acid nutrition: what about the little children? | 5.1 | 8 | Citations (PDF) |
| 93 | Circulating Folate, Vitamin B12, Homocysteine, Vitamin B12 Transport Proteins, and Risk of Prostate Cancer: a Case-Control Study, Systematic Review, and Meta-analysis | 0.9 | 134 | Citations (PDF) |
| 94 | Association of the aromatase gene with Alzheimer's disease in women | 1.9 | 33 | Citations (PDF) |
| 95 | Genetic variation in homocysteine metabolism, cognition, and white matter lesions | 3.4 | 28 | Citations (PDF) |
| 96 | Why are drug trials in Alzheimer's disease failing? | 35.3 | 14 | Citations (PDF) |
| 97 | Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled Trial | 2.5 | 608 | Citations (PDF) |
| 98 | Determinants of Plasma Methylmalonic Acid in a Large Population: Implications for Assessment of Vitamin B12 Status | 1.1 | 111 | Citations (PDF) |
| 99 | Dietary sources of vitamin B-12 and their association with plasma vitamin B-12 concentrations in the general population: the Hordaland Homocysteine Study | 5.1 | 124 | Citations (PDF) |
| 100 | Intake of Flavonoid-Rich Wine, Tea, and Chocolate by Elderly Men and Women Is Associated with Better Cognitive Test Performance | 3.0 | 207 | Citations (PDF) |
| 101 | Predicting the time of conversion to MCI in the elderly | 1.3 | 51 | Citations (PDF) |
| 102 | Vitamin B-12 and cognition in the elderly | 5.1 | 109 | Citations (PDF) |
| 103 | Beneficial effects of anti-inflammatory therapy in a mouse model of Niemann-Pick disease type C1 | 5.2 | 119 | Citations (PDF) |
| 104 | The synergy factor: a statistic to measure interactions in complex diseases | 1.6 | 94 | Citations (PDF) |
| 105 | Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease | 16.3 | 2,536 | Citations (PDF) |
| 106 | Cysteine, homocysteine and bone mineral density: A role for body composition? | 3.5 | 27 | Citations (PDF) |
| 107 | Epistasis in sporadic Alzheimer's disease | 3.4 | 99 | Citations (PDF) |
| 108 | PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients | 3.4 | 14 | Citations (PDF) |
| 109 | Replication by the Epistasis Project of the interaction between the genes for IL-6 and IL-10 in the risk of Alzheimer's disease | 9.2 | 41 | Citations (PDF) |
| 110 | The Association of Plasma Cysteine and γ‐Glutamyltransferase With BMI and Obesity | 4.3 | 58 | Citations (PDF) |
| 111 | Hydrophobic Protein that Copurifies with Human Brain Acetylcholinesterase | 4.0 | 20 | Citations (PDF) |
| 112 | Polymorphisms in the catechol‐<i>O</i>‐methyltransferase (COMT) gene influence plasma total homocysteine levels | 1.8 | 45 | Citations (PDF) |
| 113 | Butyrylcholinesterase K variant associated with higher enzyme activity in the temporal cortex of elderly patients | 1.9 | 10 | Citations (PDF) |
| 114 | The Worldwide Challenge of the Dementias: A Role for B Vitamins and Homocysteine? | 1.3 | 183 | Citations (PDF) |
| 115 | Are we ready for mandatory fortification with vitamin B-12? | 5.1 | 21 | Citations (PDF) |
| 116 | Is folic acid good for everyone? | 5.1 | 467 | Citations (PDF) |
| 117 | Reply to E Baggott and SL Morgan | 5.1 | 1 | Citations (PDF) |
| 118 | Cognitive performance among the elderly and dietary fish intake: the Hordaland Health Study | 5.1 | 131 | Citations (PDF) |
| 119 | Plasma folate concentration and cognitive performance: Rotterdam Scan Study | 5.1 | 65 | Citations (PDF) |
| 120 | Folic acid fortification: the good, the bad, and the puzzle of vitamin B-12 | 5.1 | 86 | Citations (PDF) |
| 121 | Relations of glutamate carboxypeptidase II (GCPII) polymorphisms to folate and homocysteine concentrations and to scores of cognition, anxiety, and depression in a homogeneous Norwegian population: the Hordaland Homocysteine Study | 5.1 | 28 | Citations (PDF) |
| 122 | Reply to RJ Berry et al | 5.1 | 0 | Citations (PDF) |
| 123 | Title is missing! | 9.2 | 16 | Citations (PDF) |
| 124 | Title is missing! | 9.2 | 11 | Citations (PDF) |
| 125 | The Hordaland Homocysteine Study: A Community-Based Study of Homocysteine, Its Determinants, and Associations with Disease | 3.0 | 389 | Citations (PDF) |
| 126 | Prevention of Dementia: A Role for B Vitamins? | 1.6 | 11 | Citations (PDF) |
| 127 | The association between depression, anxiety, and cognitive function in the elderly general population—the Hordaland Health Study | 2.4 | 72 | Citations (PDF) |
| 128 | Plasma total homocysteine and memory in the elderly: The Hordaland Homocysteine study | 6.6 | 136 | Citations (PDF) |
| 129 | Medial Temporal Lobe Atrophy, Apolipoprotein Genotype, and Plasma Homocysteine in Sri Lankan Patients with Alzheimer's Disease | 2.0 | 12 | Citations (PDF) |
| 130 | Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation | 2.0 | 81 | Citations (PDF) |
| 131 | Large Meta-Analysis Establishes the ACE Insertion-Deletion Polymorphism as a Marker of Alzheimer's Disease | 3.6 | 169 | Citations (PDF) |
| 132 | Low thyroid-stimulating hormone as an independent risk factor for Alzheimer disease | 1.3 | 112 | Citations (PDF) |
| 133 | Facts and Recommendations about Total Homocysteine Determinations: An Expert Opinion | 1.1 | 877 | Citations (PDF) |
| 134 | Serum levels of estradiol and testosterone and performance in different cognitive domains in healthy elderly men and women | 2.5 | 99 | Citations (PDF) |
| 135 | Association between subcortical vascular disease on CT and neuropathological findings | 2.4 | 21 | Citations (PDF) |
| 136 | Imaging the progression of Alzheimer pathology through the brain | 7.7 | 166 | Citations (PDF) |
| 137 | Plasma Homocysteine Levels, Cerebrovascular Risk Factors, and Cerebral White Matter Changes (Leukoaraiosis) in Patients With Alzheimer Disease | 6.8 | 143 | Citations (PDF) |
| 138 | Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's diseaseBrain, 2002, 125, 2332-2341 | 8.9 | 103 | Citations (PDF) |
| 139 | Homocysteine, B vitamins, and cognitive deficit in the elderly | 5.1 | 63 | Citations (PDF) |
| 140 | Human homologue of a gene mutated in the slow Wallerian degeneration (C57BL/ Wld s ) mouse | 2.4 | 22 | Citations (PDF) |
| 141 | Total Plasma Homocysteine, Age, Systolic Blood Pressure, and Cognitive Performance in Older People | 2.8 | 116 | Citations (PDF) |
| 142 | Age-Related Impairment of Synaptic Transmission But Normal Long-Term Potentiation in Transgenic Mice that Overexpress the Human APP695SWE Mutant Form of Amyloid Precursor Protein | 3.7 | 184 | Citations (PDF) |
| 143 | Association of butyrylcholinesterase K variant with cholinesterase-positive neuritic plaques in the temporal cortex in late-onset Alzheimer's disease | 3.1 | 47 | Citations (PDF) |
| 144 | Evaluation of Novel Assays in Clinical Chemistry: Quantification of Plasma Total Homocysteine | 1.1 | 82 | Citations (PDF) |
| 145 | Glutamate carboxypeptidase II: a polymorphism associated with lower levels of serum folate and hyperhomocysteinemia | 3.1 | 139 | Citations (PDF) |
| 146 | Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease | 35.3 | 418 | Citations (PDF) |
| 147 | Abnormal function of potassium channels in platelets of patients with Alzheimer's disease | 35.3 | 44 | Citations (PDF) |
| 148 | Folate, Vitamin B12, and Serum Total Homocysteine Levels in Confirmed Alzheimer Disease | 6.8 | 1,198 | Citations (PDF) |
| 149 | Longitudinal Study of Inflammatory Factors in Serum, Cerebrospinal Fluid, and Brain Tissue in Alzheimer Disease | 1.5 | 153 | Citations (PDF) |
| 150 | The Effects of Additional Pathology on the Cognitive Deficit in Alzheimer Disease | 1.9 | 193 | Citations (PDF) |
| 151 | Use of structural imaging to study the progression of Alzheimer's disease | 5.3 | 64 | Citations (PDF) |
| 152 | Amygdala input to medial prefrontal cortex (mPFC) in the rat: A light and electron microscope study | 2.5 | 149 | Citations (PDF) |
| 153 | Maxwell's role | 40.1 | 1 | Citations (PDF) |
| 154 | Coexistence of GABA and glutamate in mossy fiber terminals of the primate hippocampus: An ultrastructural study | 2.1 | 171 | Citations (PDF) |
| 155 | The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones | 13.4 | 926 | Citations (PDF) |
| 156 | Identification of synaptic terminals of thalamic or cortical origin in contact with distinct medium-size spiny neurons in the rat neostriatum | 2.1 | 297 | Citations (PDF) |
| 157 | Three dimensional analysis of retinal neuropeptides and amine in the chick | 3.4 | 45 | Citations (PDF) |
| 158 | Separation of Multiple Molecular Forms of Acetylcholinesterase by Using Affinity Chromatography: Isolation of the ‘Secretory’ Form | 4.2 | 6 | Citations (PDF) |
| 159 | Decision on folic acid fortification in Europe must consider both risks and benefits | 0.2 | 12 | Citations (PDF) |
| 160 | Anti-amyloid trials raise scientific and ethical questions | 0.2 | 6 | Citations (PDF) |
